What’s in It for Me? Contextualizing the Potential Clinical Impacts of Lecanemab, Donanemab, and Other Anti-β-amyloid Monoclonal Antibodies in Early Alzheimer’s Disease.

Details

Language :

English

ISSN :

23732822

Volume :

11

Issue :

9

Database :

Complementary Index

Journal :

eNeuro

Publication Type :

Academic Journal

Accession number :

180160449

Full Text :

https://doi.org/10.1523/ENEURO.0088-24.2024